Decreased serum BDNF contributes to the onset of REM sleep behavior disorder in Parkinson’s disease patients

[1]  J. Santamaria,et al.  Low Specificity of Rapid Eye Movement Sleep Behavior Disorder Questionnaires: Need for Better Screening Methods , 2023, Movement disorders : official journal of the Movement Disorder Society.

[2]  J. Tchekalarova,et al.  Sex-Dependent Effects of Piromelatine Treatment on Sleep-Wake Cycle and Sleep Structure of Prenatally Stressed Rats , 2022, International journal of molecular sciences.

[3]  Nuno Empadinhas,et al.  Parkinson's Disease: A Multisystem Disorder , 2022, Neuroscience Bulletin.

[4]  D. Aarsland,et al.  Parkinson disease-associated cognitive impairment , 2021, Nature Reviews Disease Primers.

[5]  R. Batista,et al.  Influence of excessive daily sleeping and sleep quality on BDNF and NGF serum levels in adolescents. , 2021, Sleep medicine.

[6]  Yixian Huang,et al.  Serum BDNF discriminates Parkinson’s disease patients with depression from without depression and reflect motor severity and gender differences , 2020, Journal of Neurology.

[7]  E. During,et al.  Sleep Issues in Parkinson’s Disease and Their Management , 2020, Neurotherapeutics.

[8]  W. Niewiadomski,et al.  BDNF as a Promising Therapeutic Agent in Parkinson’s Disease , 2020, International journal of molecular sciences.

[9]  Xinghong Jiang,et al.  Brain-derived neurotrophic factor stimulation of T-type Ca2+ channels in sensory neurons contributes to increased peripheral pain sensitivity , 2019, Science Signaling.

[10]  P. Fuller,et al.  The Biology of REM Sleep , 2017, Current Biology.

[11]  J. Sinsheimer,et al.  Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease. , 2017, Parkinsonism & related disorders.

[12]  Chun-Feng Liu,et al.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism , 2017, Neuroscience Bulletin.

[13]  E. Holsboer-trachsler,et al.  BDNF in sleep, insomnia, and sleep deprivation , 2016, Annals of medicine.

[14]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[15]  C. Mao,et al.  Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east China. , 2014, Sleep medicine.

[16]  H. Berendse,et al.  Depression and impulse control disorders in Parkinson's disease: Two sides of the same coin? , 2014, Neuroscience & Biobehavioral Reviews.

[17]  S. Brand,et al.  The Interplay of Stress and Sleep Impacts BDNF Level , 2013, PloS one.

[18]  Habib Benali,et al.  The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease , 2013, Brain : a journal of neurology.

[19]  J. Molinuevo,et al.  Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study , 2013, The Lancet Neurology.

[20]  W. Oertel,et al.  From bench to bed: putative animal models of REM sleep behavior disorder (RBD) , 2013, Journal of Neural Transmission.

[21]  D. Howells,et al.  Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons , 2005, Experimental Neurology.

[22]  M. Mahowald,et al.  REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. , 2002, Sleep.

[23]  I. Kanazawa,et al.  Dopaminergic stimulation up‐regulates the in vivo expression of brain‐derived neurotrophic factor (BDNF) in the striatum , 1992, FEBS letters.

[24]  Monika Heinzel-Gutenbrunner,et al.  Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease. , 2015, Sleep medicine.

[25]  B. Lu,et al.  BDNF and synaptic plasticity, cognitive function, and dysfunction. , 2014, Handbook of experimental pharmacology.